Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 17Dermatologic 6Gynecologic 5Thoracic 4Genitourinary 4Gastrointestinal 2CNS 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1NET 1Myeloid 1Lymphoid 1Head & Neck 1Endocrine 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 60Leukemia, Myeloid, Acute 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Myelodysplastic Syndromes 52Leukemia 47Leukemia, Myelomonocytic, Chronic 42Leukemia, Lymphocytic, Chronic, B-Cell 38Multiple Myeloma 36Lymphoma, Non-Hodgkin 36Leukemia, Myeloid, Chronic-Phase 35Myeloproliferative Disorders 34Hodgkin Disease 32Lymphoma 31Congenital Abnormalities 31Leukemia, Myeloid, Accelerated Phase 29Lymphoma, Follicular 28Burkitt Lymphoma 28Primary Myelofibrosis 27Lymphoma, Mantle-Cell 25Anemia, Refractory 25Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Large B-Cell, Diffuse 24Lymphoma, B-Cell, Marginal Zone 24Blast Crisis 22Anemia, Aplastic 19Myelodysplastic-Myeloproliferative Diseases 18Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 18Polycythemia Vera 17Dendritic Cell Sarcoma, Interdigitating 17Recurrence 16

Interventions

Epoetin Alfa 6olaparib 5pegfilgrastim 3Filgrastim 3Carboplatin 3pembrolizumab 2pegylated granulocyte colony-stimulating factor 2palbociclib 2abemaciclib 2Tretinoin 2venetoclax 1trametinib 1talazoparib 1stinging nettle lectin 1ruxolitinib 1ribociclib 1regorafenib 1ponatinib 1pertuzumab 1peppermint oil 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1fludarabine phosphate 1enzalutamide 1entrectinib 1enasidenib 1durvalumab 1dehydroftorafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × fludarabine phosphate × Classical hematology × Clear all
NCT00365287 2017-11-29

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Masonic Cancer Center, University of Minnesota

Phase 1/2 Completed
148 enrolled
BreastClassical hematologyGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Renal Cell, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡